NCT02470377

Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to determine whether external neuromodulation using repetitive transcranial magnetic stimulation (rTMS) can reduce the perception of self-motion that is experienced by individuals with mal de debarquement syndrome (MdDS). Mal de debarquement is translated as the "sickness of disembarkment," and refers to the chronic feeling of rocking dizziness that occurs after exposure to passive motion. Treatment for MdDS is limited and morbidity is high. The goal of the study is to determine whether rTMS can suppress the rocking dizziness of MdDS.

Detailed description

Participants will maintain web-based diaries of their symptoms for two weeks prior to treatment with rTMS. Up to 20 treatments with rTMS with either anatomically or functionally determined targets will be administered. Post treatment diaries will continue for up to 12 weeks after rTMS administration.

Conditions

• Mal de Debarquement Syndrome

Interventions

Type	Name	Description
DEVICE	Transcranial Magnetic Stimulation	A form of external neuromodulation using pulsatile magnetic fields on the surface of the head.

Timeline

• Start date: 2015-08-01
• Primary completion: 2017-07-01
• Completion: 2017-07-01
• First posted: 2015-06-12
• Last updated: 2022-08-31
• Results posted: 2022-08-31

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study